Major inhibitors of the contact phase coagulation factors.
D000799:Angioedema / Q000097:blood / Q000235:genetics; D001778:Blood Coagulation Disorders / Q000097:blood*; D003101:Collodion; D003174:Complement C1 Inactivator Proteins / Q000235:genetics / Q000502:physiology; D004591:Electrophoresis, Polyacrylamide Gel; D005172:Factor XI / Q000037:antagonists & inhibitors*; D005174:Factor XII / Q000037:antagonists & inhibitors* / Q000502:physiology; D015956:Factor XIIa; D015945:Factor XIa; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors*; D007700:Kinetics; D010446:Peptide Fragments / Q000037:antagonists & inhibitors* / Q000502:physiology; D011480:Protease Inhibitors / Q000097:blood; D011485:Protein Binding; D011863:Radioimmunoassay; D011994:Recombinant Proteins / Q000502:physiology; D000515:alpha 1-Antitrypsin / Q000502:physiology; D000511:alpha-Macroglobulins / Q000502:physiology
D003174:Complement C1 Inactivator Proteins; D010446:Peptide Fragments; D011480:Protease Inhibitors; D011994:Recombinant Proteins; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D005174:Factor XII; D003101:Collodion; D005172:Factor XI; D007610:Kallikreins; D015945:Factor XIa; D015956:Factor XIIa